CA Stock MarketDetailed Quotes
LABS MediPharm Labs Corp
- 0.065
- 0.0000.00%
15min DelayMarket Closed Dec 27 16:00 ET
26.72MMarket Cap-2.17P/E (TTM)
0.065High0.060Low127.97KVolume0.060Open0.065Pre Close7.82KTurnover0.10052wk High0.03%Turnover Ratio411.12MShares0.06052wk Low-0.03EPS TTM24.64MFloat Cap7.390Historical HighLossP/E (Static)379.07MShs Float0.055Historical Low-0.04EPS LYR7.69%Amplitude--Dividend TTM0.59P/B1Lot Size--Div YieldTTM
MediPharm Labs Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 79.52%-662K | 78.67%-1.61M | 49.98%-1.53M | 23.21%-12.34M | 977.38%1.47M | -11.95%-3.23M | -1.59%-7.53M | 45.54%-3.05M | -21.62%-16.07M | 95.85%-168K |
| Net income from continuing operations | 35.89%-2.77M | 10.34%-2.58M | -16.94%-3.61M | 56.37%-13.08M | 50.31%-2.79M | 45.44%-4.33M | 67.94%-2.88M | 58.59%-3.09M | 45.29%-29.98M | 74.23%-5.61M |
| Operating gains losses | -94.74%2K | -108.90%-21K | -6,480.00%-319K | -70.47%269K | -100.91%-10K | 103.16%38K | -82.28%236K | 101.58%5K | 131.31%911K | 540.56%1.1M |
| Depreciation and amortization | -16.05%518K | 5.64%731K | 61.22%790K | -12.40%2.52M | 32.78%717K | -18.17%617K | -8.83%692K | -40.17%490K | -49.01%2.87M | -77.34%540K |
| Asset impairment expenditure | -110.20%-31K | -83.60%166K | --234K | 27.76%1.75M | 138.52%433K | -84.58%304K | --1.01M | --0 | -89.40%1.37M | -116.87%-1.12M |
| Remuneration paid in stock | --0 | 82.76%-80K | 101.49%23K | -1,534.33%-1.92M | 129.81%48K | -86.44%40K | ---464K | ---1.55M | -98.03%134K | -102.61%-161K |
| Remuneration paid in stock | -58.55%160K | -2.04%576K | 19.81%895K | -29.42%2.03M | -77.99%306K | 139.75%386K | 1.38%588K | 0.81%747K | 19.57%2.87M | 127.50%1.39M |
| Other non cashItems | 137.07%585K | 103.48%180K | 73.06%-66K | -1,420.70%-7.35M | -46.64%-349K | -1,260.34%-1.58M | -6,208.54%-5.17M | -421.28%-245K | -104.70%-483K | 4.03%-238K |
| Change In working capital | -31.83%878K | 62.66%-575K | -9.90%528K | -44.70%3.45M | -20.85%3.12M | -59.47%1.29M | -0.33%-1.54M | -11.08%586K | -1.83%6.24M | 65.49%3.94M |
| -Change in receivables | -105.65%-473K | -64.56%319K | -2,700.00%-616K | 77.74%6.42M | 318.87%5.77M | -314.95%-230K | 1,204.35%900K | -101.07%-22K | -64.55%3.61M | -79.71%1.38M |
| -Change in inventory | -90.08%221K | 107.68%37K | -106.68%-80K | 3,123.30%3.11M | -85.48%171K | 21.96%2.23M | 78.05%-482K | 231.50%1.2M | -104.14%-103K | 18.75%1.18M |
| -Change in payables and accrued expense | 146.04%553K | 68.43%-601K | 336.68%1.88M | -446.48%-5.17M | -269.80%-1.27M | -439.27%-1.2M | -535.70%-1.9M | -1,668.89%-796K | 118.39%1.49M | 119.99%745K |
| -Change in other current assets | -53.28%377K | -37.65%-819K | 59.00%159K | -160.89%-1.07M | -291.93%-1.38M | -30.61%807K | -54.15%-595K | -61.24%100K | 152.01%1.75M | 3.30%719K |
| -Change in other current liabilities | ---- | ---- | ---- | 129.13%150K | ---- | ---- | ---- | ---- | -147.12%-515K | -126.95%-83K |
| -Change in other working capital | 163.49%200K | ---- | -872.64%-819K | ---- | ---- | ---315K | ---- | --106K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 79.52%-662K | 78.67%-1.61M | 49.98%-1.53M | 23.21%-12.34M | 977.38%1.47M | -11.95%-3.23M | -1.59%-7.53M | 45.54%-3.05M | -21.62%-16.07M | 95.85%-168K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -102.01%-33K | -103.70%-35K | 2,200.00%525K | 33.23%6.87M | -24.49%4.31M | 619.94%1.64M | 1,187.36%946K | 82.64%-25K | 14,637.14%5.16M | 1,937.50%5.71M |
| Capital expenditure reported | 87.31%-33K | 16.42%-56K | 16.00%-21K | 45.42%-471K | 61.49%-119K | 17.72%-260K | 28.72%-67K | 82.64%-25K | -10.22%-863K | -50.00%-309K |
| Net PPE purchase and sale | --0 | --21K | --326K | --178K | 2,642.86%178K | --0 | --0 | --0 | --0 | 66.67%-7K |
| Net business purchase and sale | --0 | ---- | ---- | -12.50%5.26M | -29.35%4.25M | --0 | ---- | ---- | --6.01M | --6.01M |
| Net other investing changes | ---- | --0 | --220K | 27,085.71%1.9M | --0 | --1.9M | ---- | ---- | -98.62%7K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -102.01%-33K | -103.70%-35K | 2,200.00%525K | 33.23%6.87M | -24.49%4.31M | 619.94%1.64M | 1,187.36%946K | 82.64%-25K | 14,637.14%5.16M | 1,937.50%5.71M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -643.14%-2.22M | -37.21%685K | 92.82%-66K | -146.23%-368K | 39.60%-241K | -109.09%-299K | -19.30%1.09M | -6,464.29%-919K | -97.14%796K | -40,000.00%-399K |
| Net issuance payments of debt | -477.84%-2.24M | -40.40%596K | 76.91%-269K | -340.20%-944K | 27.32%-391K | -40.07%-388K | -21.26%1M | -1,779.03%-1.17M | 113.27%393K | -564.20%-538K |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | -75.29%-149K | -13.27%-111K | -425.00%-21K | -915.38%-264K | -196.15%-77K | -4,350.00%-85K | -4,800.00%-98K | ---4K | -116.67%-26K | ---26K |
| Net other financing activities | -2.87%169K | 5.82%200K | -10.40%224K | 95.80%840K | 37.58%227K | 31.82%174K | 125.00%189K | 420.83%250K | 408.63%429K | 75.53%165K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -643.14%-2.22M | -37.21%685K | 92.82%-66K | -146.23%-368K | 39.60%-241K | -109.09%-299K | -19.30%1.09M | -6,464.29%-919K | -97.14%796K | -40,000.00%-399K |
| Net cash flow | ||||||||||
| Beginning cash position | 8.47%15.99M | -16.00%16.93M | -25.53%17.98M | -29.21%24.15M | -33.43%12.95M | -32.97%14.74M | -28.73%20.15M | -29.21%24.15M | 71.30%34.11M | -48.75%19.45M |
| Current changes in cash | -54.50%-2.92M | 82.60%-956K | 73.29%-1.07M | 42.31%-5.84M | 7.84%5.54M | 43.57%-1.89M | 10.64%-5.49M | 30.64%-4M | -169.16%-10.12M | 236.50%5.14M |
| Effect of exchange rate changes | -81.25%18K | -75.29%21K | --12K | -319.33%-329K | -14.09%-510K | -88.12%96K | 163.43%85K | --0 | 134.97%150K | -432.14%-447K |
| End cash Position | 1.10%13.09M | 8.47%15.99M | -16.00%16.93M | -25.53%17.98M | -25.53%17.98M | -33.43%12.95M | -32.97%14.74M | -28.73%20.15M | -29.21%24.15M | -29.21%24.15M |
| Free cash from | 80.10%-695K | 78.12%-1.66M | 49.71%-1.55M | 24.34%-12.81M | 384.07%1.36M | -9.02%-3.49M | -1.21%-7.6M | 46.47%-3.08M | -20.98%-16.93M | 88.78%-477K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data